BTG Pactual Global Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
BTG Pactual Global Asset Management's GILD Position: Q2 2022 in Review
BTG Pactual Global Asset Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 5,748 shares — an estimated $342K sold.
BTG Pactual Global Asset Management first reported a position in GILD in Q4 2013 and held it in 15 quarters. The position peaked at $929K in Q2 2017. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.
- BTG Pactual Global Asset Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
- BTG Pactual Global Asset Management sold 5,748 Gilead Sciences shares in Q2 2022, an estimated $342K.
- BTG Pactual Global Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 15 quarters.
- BTG Pactual Global Asset Management's Gilead Sciences position peaked at $929K in Q2 2017.
- 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.
Based on BTG Pactual Global Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.